| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Early Detection of Cancer | 8 | 2022 | 409 | 2.440 |
Why?
|
| Colorectal Neoplasms | 8 | 2022 | 970 | 2.280 |
Why?
|
| Aortic Aneurysm, Thoracic | 9 | 2021 | 89 | 2.060 |
Why?
|
| Emigrants and Immigrants | 6 | 2018 | 44 | 1.790 |
Why?
|
| Blood Vessel Prosthesis Implantation | 9 | 2021 | 224 | 1.710 |
Why?
|
| Transcatheter Aortic Valve Replacement | 7 | 2021 | 51 | 1.650 |
Why?
|
| Endovascular Procedures | 10 | 2021 | 264 | 1.510 |
Why?
|
| Aortic Valve | 8 | 2021 | 243 | 1.280 |
Why?
|
| Aortic Aneurysm | 5 | 2020 | 80 | 1.230 |
Why?
|
| Patient Navigation | 3 | 2018 | 13 | 1.200 |
Why?
|
| Colonoscopy | 3 | 2022 | 274 | 1.050 |
Why?
|
| Aortic Valve Stenosis | 3 | 2021 | 143 | 1.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2020 | 177 | 1.000 |
Why?
|
| Heart Valve Prosthesis | 5 | 2021 | 97 | 0.730 |
Why?
|
| Hepatitis B, Chronic | 2 | 2018 | 33 | 0.700 |
Why?
|
| Computed Tomography Angiography | 4 | 2022 | 139 | 0.690 |
Why?
|
| Aortography | 2 | 2018 | 64 | 0.660 |
Why?
|
| Communication Barriers | 1 | 2018 | 29 | 0.620 |
Why?
|
| Chicago | 7 | 2020 | 1411 | 0.610 |
Why?
|
| Intention | 1 | 2018 | 50 | 0.610 |
Why?
|
| Health Education | 1 | 2018 | 101 | 0.590 |
Why?
|
| Middle Aged | 30 | 2021 | 25699 | 0.580 |
Why?
|
| Software | 1 | 2021 | 663 | 0.560 |
Why?
|
| Public Health Surveillance | 1 | 2016 | 21 | 0.550 |
Why?
|
| Bioprosthesis | 3 | 2021 | 39 | 0.540 |
Why?
|
| Aged | 22 | 2021 | 18932 | 0.530 |
Why?
|
| Humans | 53 | 2022 | 88611 | 0.520 |
Why?
|
| Education, Public Health Professional | 1 | 2015 | 2 | 0.520 |
Why?
|
| Women's Health | 1 | 2016 | 102 | 0.510 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 36 | 0.510 |
Why?
|
| Urban Health | 1 | 2015 | 56 | 0.510 |
Why?
|
| Gastrointestinal Diseases | 1 | 2016 | 149 | 0.490 |
Why?
|
| Colonic Polyps | 1 | 2015 | 130 | 0.480 |
Why?
|
| Female | 35 | 2022 | 45759 | 0.470 |
Why?
|
| Mass Screening | 4 | 2020 | 631 | 0.460 |
Why?
|
| Male | 35 | 2022 | 42012 | 0.450 |
Why?
|
| Health Status Disparities | 1 | 2015 | 181 | 0.440 |
Why?
|
| Retrospective Studies | 19 | 2022 | 8893 | 0.430 |
Why?
|
| Primary Health Care | 1 | 2016 | 350 | 0.420 |
Why?
|
| Michigan | 7 | 2021 | 53 | 0.420 |
Why?
|
| Treatment Outcome | 16 | 2022 | 8178 | 0.420 |
Why?
|
| Education, Medical | 1 | 2015 | 243 | 0.410 |
Why?
|
| Stents | 4 | 2021 | 395 | 0.370 |
Why?
|
| Aorta | 3 | 2021 | 286 | 0.370 |
Why?
|
| Endocarditis, Bacterial | 2 | 2020 | 34 | 0.370 |
Why?
|
| Hospital Mortality | 7 | 2020 | 381 | 0.360 |
Why?
|
| Minority Groups | 3 | 2020 | 140 | 0.350 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2021 | 241 | 0.350 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 248 | 0.350 |
Why?
|
| Acute Disease | 6 | 2022 | 838 | 0.320 |
Why?
|
| Time Factors | 9 | 2021 | 5319 | 0.320 |
Why?
|
| Mesenteric Ischemia | 2 | 2018 | 7 | 0.310 |
Why?
|
| Religion and Psychology | 1 | 2006 | 18 | 0.290 |
Why?
|
| Community-Institutional Relations | 1 | 2006 | 29 | 0.280 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 436 | 0.280 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 473 | 0.270 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 3655 | 0.270 |
Why?
|
| Behavior Therapy | 1 | 2006 | 83 | 0.270 |
Why?
|
| Rural Population | 1 | 2006 | 143 | 0.270 |
Why?
|
| Spirituality | 1 | 2006 | 87 | 0.270 |
Why?
|
| China | 3 | 2020 | 230 | 0.270 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2006 | 39 | 0.260 |
Why?
|
| Ischemia | 2 | 2018 | 251 | 0.260 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2006 | 42 | 0.260 |
Why?
|
| Religion and Medicine | 1 | 2006 | 124 | 0.250 |
Why?
|
| Weight Loss | 1 | 2006 | 225 | 0.250 |
Why?
|
| United States | 9 | 2020 | 6882 | 0.250 |
Why?
|
| Insurance Coverage | 2 | 2015 | 119 | 0.240 |
Why?
|
| Healthcare Disparities | 4 | 2016 | 396 | 0.240 |
Why?
|
| Aorta, Thoracic | 2 | 2021 | 166 | 0.230 |
Why?
|
| Adult | 10 | 2020 | 26348 | 0.220 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2015 | 525 | 0.220 |
Why?
|
| Evidence-Based Medicine | 3 | 2020 | 431 | 0.220 |
Why?
|
| Curriculum | 3 | 2015 | 565 | 0.210 |
Why?
|
| Risk Factors | 8 | 2021 | 5449 | 0.210 |
Why?
|
| Risk Assessment | 5 | 2018 | 2286 | 0.200 |
Why?
|
| Text Messaging | 1 | 2022 | 30 | 0.200 |
Why?
|
| Genetic Testing | 1 | 2006 | 538 | 0.200 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2021 | 29 | 0.200 |
Why?
|
| Diverticulum | 1 | 2021 | 45 | 0.190 |
Why?
|
| Long Term Adverse Effects | 1 | 2020 | 6 | 0.180 |
Why?
|
| Hepatitis B Surface Antigens | 2 | 2018 | 25 | 0.180 |
Why?
|
| Intercostal Nerves | 1 | 2020 | 3 | 0.180 |
Why?
|
| Risk | 2 | 2020 | 660 | 0.180 |
Why?
|
| Endocarditis | 1 | 2020 | 21 | 0.180 |
Why?
|
| Denervation | 1 | 2020 | 24 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 196 | 0.180 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 119 | 0.180 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 6723 | 0.180 |
Why?
|
| Obesity | 1 | 2006 | 972 | 0.180 |
Why?
|
| Neoplasms | 1 | 2015 | 3009 | 0.180 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 80 | 0.180 |
Why?
|
| Abscess | 1 | 2020 | 94 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 143 | 0.170 |
Why?
|
| Cryosurgery | 1 | 2020 | 52 | 0.170 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 60 | 0.170 |
Why?
|
| Marketing of Health Services | 1 | 2019 | 15 | 0.170 |
Why?
|
| Patient Admission | 1 | 2020 | 113 | 0.170 |
Why?
|
| Panax | 2 | 2011 | 170 | 0.170 |
Why?
|
| Narcotics | 1 | 2020 | 70 | 0.170 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 114 | 0.170 |
Why?
|
| Hospitals, High-Volume | 1 | 2019 | 37 | 0.170 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 155 | 0.170 |
Why?
|
| Postoperative Complications | 5 | 2021 | 2285 | 0.170 |
Why?
|
| Splanchnic Circulation | 1 | 2018 | 15 | 0.170 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 227 | 0.160 |
Why?
|
| Informed Consent | 1 | 2021 | 273 | 0.160 |
Why?
|
| Pain Management | 1 | 2020 | 134 | 0.160 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 365 | 0.160 |
Why?
|
| Chronic Disease | 2 | 2020 | 948 | 0.160 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2020 | 120 | 0.160 |
Why?
|
| Occult Blood | 1 | 2018 | 16 | 0.160 |
Why?
|
| Aortic Rupture | 1 | 2018 | 57 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2021 | 454 | 0.160 |
Why?
|
| Device Removal | 1 | 2020 | 167 | 0.160 |
Why?
|
| Hospitals, University | 1 | 2018 | 195 | 0.160 |
Why?
|
| Vascular Calcification | 1 | 2018 | 51 | 0.150 |
Why?
|
| Forecasting | 1 | 2018 | 305 | 0.150 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 606 | 0.150 |
Why?
|
| Registries | 1 | 2021 | 759 | 0.150 |
Why?
|
| Health Expenditures | 1 | 2018 | 91 | 0.150 |
Why?
|
| Community Health Services | 1 | 2018 | 82 | 0.140 |
Why?
|
| Viscera | 1 | 2016 | 17 | 0.140 |
Why?
|
| Influenza, Human | 1 | 2020 | 333 | 0.140 |
Why?
|
| Reoperation | 4 | 2020 | 605 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 837 | 0.140 |
Why?
|
| Prognosis | 3 | 2020 | 3750 | 0.140 |
Why?
|
| Hospitals | 1 | 2019 | 298 | 0.140 |
Why?
|
| Seroepidemiologic Studies | 1 | 2016 | 55 | 0.140 |
Why?
|
| Patient Participation | 1 | 2018 | 224 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 414 | 0.130 |
Why?
|
| Directive Counseling | 1 | 2016 | 35 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 454 | 0.130 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 97 | 0.130 |
Why?
|
| Vietnam | 1 | 2015 | 14 | 0.130 |
Why?
|
| Cambodia | 1 | 2015 | 6 | 0.130 |
Why?
|
| Polyps | 1 | 2015 | 29 | 0.130 |
Why?
|
| Thrombosis | 1 | 2018 | 301 | 0.130 |
Why?
|
| Cultural Diversity | 2 | 2013 | 53 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2018 | 342 | 0.130 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 67 | 0.120 |
Why?
|
| Schools, Medical | 2 | 2013 | 134 | 0.120 |
Why?
|
| Communication | 1 | 2018 | 452 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 308 | 0.120 |
Why?
|
| Universities | 1 | 2015 | 146 | 0.120 |
Why?
|
| Logistic Models | 1 | 2018 | 1205 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1039 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1709 | 0.110 |
Why?
|
| Sexual and Gender Minorities | 1 | 2016 | 201 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1167 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 577 | 0.110 |
Why?
|
| Personnel Selection | 1 | 2013 | 60 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2746 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1863 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2011 | 136 | 0.090 |
Why?
|
| Faculty, Medical | 1 | 2013 | 184 | 0.090 |
Why?
|
| Decision Making | 1 | 2016 | 661 | 0.090 |
Why?
|
| School Admission Criteria | 1 | 2010 | 23 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2011 | 520 | 0.090 |
Why?
|
| Ginsenosides | 1 | 2011 | 123 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2011 | 244 | 0.090 |
Why?
|
| Sex Factors | 1 | 2012 | 1063 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 447 | 0.080 |
Why?
|
| Pain Measurement | 2 | 2020 | 329 | 0.080 |
Why?
|
| Physicians | 1 | 2016 | 684 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2011 | 496 | 0.080 |
Why?
|
| Regional Blood Flow | 2 | 2018 | 198 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 566 | 0.070 |
Why?
|
| Diet, Reducing | 1 | 2006 | 30 | 0.070 |
Why?
|
| North Carolina | 1 | 2006 | 50 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2015 | 4271 | 0.070 |
Why?
|
| Focus Groups | 1 | 2006 | 164 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 597 | 0.070 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2008 | 178 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2006 | 172 | 0.060 |
Why?
|
| Family Health | 1 | 2006 | 162 | 0.060 |
Why?
|
| Survival Rate | 2 | 2020 | 1883 | 0.060 |
Why?
|
| Leadership | 1 | 2006 | 136 | 0.060 |
Why?
|
| Students, Medical | 1 | 2010 | 418 | 0.060 |
Why?
|
| Internal Medicine | 1 | 2008 | 356 | 0.060 |
Why?
|
| Young Adult | 1 | 2016 | 6218 | 0.060 |
Why?
|
| Adolescent | 1 | 2016 | 9157 | 0.060 |
Why?
|
| Exercise | 1 | 2006 | 322 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2006 | 770 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2020 | 2837 | 0.050 |
Why?
|
| Cathartics | 1 | 2022 | 27 | 0.050 |
Why?
|
| Subclavian Artery | 1 | 2021 | 43 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2021 | 48 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2021 | 161 | 0.050 |
Why?
|
| Aftercare | 1 | 2021 | 87 | 0.050 |
Why?
|
| Medical Overuse | 1 | 2020 | 36 | 0.050 |
Why?
|
| Introns | 1 | 2021 | 298 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2021 | 242 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 59 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2020 | 293 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2593 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 199 | 0.040 |
Why?
|
| Vascular Grafting | 1 | 2018 | 15 | 0.040 |
Why?
|
| Episode of Care | 1 | 2018 | 7 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 318 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 233 | 0.040 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 15 | 0.040 |
Why?
|
| Hepatitis B virus | 1 | 2018 | 44 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 149 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2022 | 443 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 865 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 108 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 279 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 2322 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2018 | 303 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1851 | 0.030 |
Why?
|
| Kidney | 1 | 2022 | 1145 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2016 | 37 | 0.030 |
Why?
|
| Stereotyping | 1 | 2016 | 15 | 0.030 |
Why?
|
| Genome, Human | 1 | 2021 | 767 | 0.030 |
Why?
|
| Health Communication | 1 | 2016 | 13 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 275 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 32 | 0.030 |
Why?
|
| Culture | 1 | 2016 | 53 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1542 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 726 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 689 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2015 | 160 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 760 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1592 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1662 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1977 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 360 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 418 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2013 | 333 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2013 | 285 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 622 | 0.020 |
Why?
|
| Heart Failure | 1 | 2020 | 1171 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 193 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 315 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 4097 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 684 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 374 | 0.020 |
Why?
|
| Colon | 1 | 2011 | 505 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1868 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 2638 | 0.020 |
Why?
|
| Bacteria | 1 | 2011 | 468 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 1694 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 829 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3445 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 804 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2538 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 2346 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 11710 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 27233 | 0.010 |
Why?
|